Nyxoah SA (EBR:NYXH)
3.600
-0.130 (-3.49%)
At close: Mar 2, 2026
Nyxoah Revenue
Nyxoah had revenue of 1.97M EUR in the quarter ending September 30, 2025, with 55.77% growth. This brings the company's revenue in the last twelve months to 5.64M, up 10.96% year-over-year. In the year 2024, Nyxoah had annual revenue of 4.52M with 3.98% growth.
Revenue (ttm)
5.64M
Revenue Growth
+10.96%
P/S Ratio
27.47
Revenue / Employee
30.65K
Employees
184
Market Cap
154.90M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.52M | 173.00K | 3.98% |
| Dec 31, 2023 | 4.35M | 1.26M | 40.99% |
| Dec 31, 2022 | 3.08M | 2.23M | 261.97% |
| Dec 31, 2021 | 852.00K | 783.00K | 1,134.78% |
| Dec 31, 2020 | 69.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UCB SA | 7.74B |
| argenx SE | 3.62B |
| Fagron NV | 952.17M |
| Ion Beam Applications | 585.76M |
| European Medical Solutions | 49.47M |
| Hyloris Pharmaceuticals | 8.46M |
| Onward Medical | 2.72M |
| Celyad Oncology | 186.00K |
Nyxoah News
- 11 days ago - Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East - GlobeNewsWire
- 5 weeks ago - Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth - GlobeNewsWire
- 5 weeks ago - Nyxoah SA (NYXH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Publication relating to transparency notification - GlobeNewsWire
- 2 months ago - Nyxoah Announces Issuance of First Tranche of Convertible Bonds - GlobeNewsWire
- 2 months ago - Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands - GlobeNewsWire
- 3 months ago - Publication relating to transparency notifications - GlobeNewsWire
- 3 months ago - Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire